Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the Leerink Swann
Oncology Roundtable Conference on May 20 in New York City. The public is
welcome to participate in the conference through a webcast on the Array
BioPharma website.
|
|
|
|
|
Event:
|
|
Leerink Swann Oncology Roundtable Conference
|
|
Presenter:
|
|
Robert E. Conway, Chief Executive Officer, Array BioPharma
|
|
Date:
|
|
Wednesday, May 20, 2009
|
|
Time:
|
|
2:30 p.m. Eastern Time
|
|
Location:
|
|
Roosevelt Hotel, New York City
|
|
Webcast:
|
|
www.arraybiopharma.com
|
|
|
|
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer, inflammatory and
metabolic diseases. Our proprietary drug development pipeline includes
clinical candidates that are designed to regulate therapeutically
important target proteins and are aimed at significant unmet medical
needs. In addition, leading pharmaceutical and biotechnology companies
collaborate with Array to discover and develop drug candidates across a
broad range of therapeutic areas. For more information on Array, please
go to www.arraybiopharma.com.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com
